36 天前 - … for advanced non-small-cell lung cancer (NSCLC) … progression on first-line
EGFR-TKIs, but chemotherapy other … -TKIs (gefitinib, erlotinib or afatinib) as first-line treatment and …

79 天前 - … as regard response to first line treatment between exon 19 … survival after first line
treatment Gefitinib between exon 19 … new clinical trials for chemotherapy-naïve, EGFR mutation…

103 天前 - … standard of care for first line therapy of advanced non-small cell lung cancer (NSCLC) …
of two novel therapeutic options combining platinum-based chemotherapy in association …

113 天前 - … advanced non–small-cell lung cancer (NSCLC) who received either gefitinib or
gefitinib with chemotherapy (pemetrexed and carboplatin) as first-line therapy in a prospective …

114 天前 - … as first-line treatment for patients with non-small-cell lung … terms were used: “non-small-cell
lung cancer”, “first line”,” … (range) durations of gefitinib administration in the NEJ009 …

115 天前 - … therapy consisting of gefitinib, bevacizumab, pemetrexed, and carboplatin in patients
with advanced non-squamous non–small cell lung cancer (… EGFR-mutated advanced non-…

166 天前 - … first-line treatment with gefitinib combined with radiotherapy for vertebral metastases.
However, the patient developed … Systemic chemotherapy is the primary treatment for driver …

182 天前 - … Gefitinib or chemotherapy for non–small-cell lung cancer with mutated … first-line
treatment of locally advanced or metastatic EGFR mutation positive non-small cell lung cancer in …

204 天前 - … for OS: 67 had first line osimertinib, 115 gefitinib/erlotinib, and 24 chemotherapy
(CT). … In ALK/ROS1+, 31 pts had first line target therapy, 19 had CT. mOS was 22.1 (95%CI …

204 天前 - … Patients started treatment with osimertinib as first-line therapy in 66.6%, 23.1% as …
Previous therapies received: erlotinib (n=3), gefitinib (n=5), afatinib (n=5), chemotherapy (n=4)…